๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

โœ Scribed by John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. Cornett

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
481 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female participants. Screening for prostate cancer is by prostate specific antigen and digital rectal examination. A coordinating center and 10 screening centers located across the United States, a laboratory for prostate specific antigen and CA125 assays, and a biorepository are the primary components of the trial. Scientific direction is provided by National Cancer Institute scientific staff, a steering committee of study investigators, external expert consultants, and a data monitoring panel. Evaluation of the pilot phase is focused on recruitment; screening operations, including quality assurance; compliance; data management; and blood processing. Pilot phase results are anticipated in 1995.

๐Ÿ“œ SIMILAR VOLUMES

Chemoprevention of prostate cancer: The
Chemoprevention of prostate cancer: The prostate cancer prevention trial
โœ Thompson, Ian M.; Coltman, Charles A.; Crowley, John ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB ๐Ÿ‘ 1 views

## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the

A comparison of breast, colorectal, lung
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results program
โœ Curtis J. Mettlin; Herman R. Menck; David P. Winchester; Gerald P. Murphy ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 2 views

## Background: The national cancer data base (ncdb) is an information resource and program evaluation tool of the american college of surgeons commission on cancer and the american cancer society that uses a hospital-based cancer reporting system. the surveillance, epidemiology, and end results (se

Randomized population trials and screeni
Randomized population trials and screening for lung cancer : Breaking the cure barrier
โœ Gary M. Strauss ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 212 KB ๐Ÿ‘ 2 views

## BACKGROUND. At the current time, there is nearly universal agreement that screening for the early detection of lung carcinoma is not justified. This is based on the fact that, to the author's knowledge, no randomized population trial (RPT) to date has demonstrated a significant reduction in lun